Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4296294 Target Snapshot

DNA-directed RNA polymerase subunit beta · SINGLE PROTEIN · Escherichia coli O127:H6 (strain E2348/69 / EPEC)

5Compounds
3Assays
0Approved Drugs
15.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt B7UPE2. Use UniProt B7UPE2 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt B7UPE2 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats DNA-directed RNA polymerase subunit beta as ChEMBL target CHEMBL4296294, mapped to UniProt B7UPE2. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
DNA-directed RNA polymerase subunit beta
SINGLE PROTEIN · Escherichia coli O127:H6 (strain E2348/69 / EPEC)
As of 2026-09-14
ChEMBL target ID
CHEMBL4296294
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
B7UPE2
DNA-directed RNA polymerase subunit beta
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether DNA-directed RNA polymerase subunit beta is the right protein anchor across sources, using UniProt B7UPE2 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDNA-directed RNA polymerase subunit beta
UniProt AccessionB7UPE2
Component TypeProtein
Sequence Length1342 aa

DNA-directed RNA polymerase subunit beta

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as DNA-directed RNA polymerase subunit beta, mapped to UniProt B7UPE2. Sequence length is 1342 aa.

Mapped IDB7UPE2
Review nameDNA-directed RNA polymerase subunit beta
OrganismEscherichia coli O127:H6 (strain E2348/69 / EPEC)
Clinical Profile

Clinical Phase Distribution

1
Phase III
Assay Mix

Activity Type Distribution

IC5015.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2046886 5.7 IC50 2000.0 Preclinical
CHEMBL2046887 4.89 IC50 13000.0 Preclinical
CHEMBL2046885 4.46 IC50 35000.0 Preclinical
CHEMBL236297 4.2 IC50 63000.0 Clinical
Distribution

pChEMBL Value Distribution

0
5.0
1
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

3
Total Assays
5
Tested Compounds
1
Assay Types
Binding — 3 assays, 5 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 5 4.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine